H2 acquires Optegra

H2 is currently investing from H2 Equity Partners Fund V, which closed on £200m in March 2016. The fund has a history of investing in the healthcare sector, with investments such as medical equipment distributor Healthcare 21 and healthcare products provider Aquilant.

The process was formally launched in August 2020, according to Unquote sister publication Mergermarket. The report noted the asset would be marketed based on pro forma EBITDA of $5-9m for the year to June 2021, with revenues in the $80-90m range.

Completion of the acquisition will occur following satisfaction of certain regulatory conditions and is expected to take place early in 2021.

H2 declined to comment.

Company
In the UK, Optegra operates seven dedicated eye hospitals in Birmingham, Hampshire, Manchester, London, Surrey and Yorkshire; its newest hospital opened in the Harley Street district of central London in 2015. Optegra also offers ophthalmic services in China, Germany, the Czech Republic and Poland. Founded in 2008, the company is headquartered in Guildford.

People
H2 Equity Partners – Patrick Kalverboer (managing partner); Cathal Turley (investment director).

Advisers
Vendor – William Blair (corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Exits
• UK / Ireland
• Healthcare
• H2 Equity Partners
• Secondary buyout
• United Kingdom